Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Total Stockholders Equity : NT$228.8 Mil (As of Jun. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Taiwan Advance Bio-Pharmaceutical Total Stockholders Equity?

Taiwan Advance Bio-Pharmaceutical's Total Stockholders Equity for the quarter that ended in Jun. 2024 was NT$228.8 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Taiwan Advance Bio-Pharmaceutical's Book Value per Share for the quarter that ended in Jun. 2024 was NT$2.54. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Taiwan Advance Bio-Pharmaceutical's Debt-to-Equity for the quarter that ended in Jun. 2024 was 1.29.

Taiwan Advance Bio-Pharmaceutical Total Stockholders Equity Historical Data

The historical data trend for Taiwan Advance Bio-Pharmaceutical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Advance Bio-Pharmaceutical Total Stockholders Equity Chart

Taiwan Advance Bio-Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

195.20

358.90

241.45

244.64

233.92

Taiwan Advance Bio-Pharmaceutical Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Stockholders Equity	Get a 7-Day Free Trial															249.29	244.64	208.14	233.92	228.81

Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Taiwan Advance Bio-Pharmaceutical's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(228.814	-	0)	/	90
	=	2.54

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Taiwan Advance Bio-Pharmaceutical's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(224.932	+	70.51)	/	228.814
	=	1.29

Taiwan Advance Bio-Pharmaceutical Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Taiwan Advance Bio-Pharmaceutical's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiwan Advance Bio-Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Advance Bio-Pharmaceutical Inc (ROCO:4186) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

12F., No.25, Ln. 169, Kangning Street, Xizhi Dist, New Taipei City, TWN, 22180

Website

http://www.abc-residue.com

Taiwan Advance Bio-Pharmaceutical Inc operates in the food safety industry. The company's product includes Food safety test kit, Animal test kit, Pesticide test kit, Mycotoxin test kit, Nuleic acid extraction kit.

Taiwan Advance Bio-Pharmaceutical Headlines

No Headlines